Increased ER Stress and Unfolded Protein Response Activation in Epithelial and Inflammatory Cells in Hypersensitivity Pneumonitis.
Sandra CabreraÁngeles García-VicentePamela GutiérrezAndrea SánchezMiguel GaxiolaCarolina Rodríguez-BobadillaMoisés SelmanAnnie PardoPublished in: The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society (2024)
Several types of cytotoxic insults disrupt endoplasmic reticulum (ER) homeostasis, cause ER stress, and activate the unfolded protein response (UPR). The role of ER stress and UPR activation in hypersensitivity pneumonitis (HP) has not been described. HP is an immune-mediated interstitial lung disease that develops following repeated inhalation of various antigens in susceptible and sensitized individuals. The aim of this study was to investigate the lung expression and localization of the key effectors of the UPR, BiP/GRP78, CHOP, and sXBP1 in HP patients compared with control subjects. Furthermore, we developed a mouse model of HP to determine whether ER stress and UPR pathway are induced during this pathogenesis. In human control lungs, we observed weak positive staining for BiP in some epithelial cells and macrophages, while sXBP1 and CHOP were negative. Conversely, strong BiP, sXBP1- and CHOP-positive alveolar and bronchial epithelial, and inflammatory cells were identified in HP lungs. We also found apoptosis and autophagy markers colocalization with UPR proteins in HP lungs. Similar results were obtained in lungs from an HP mouse model. Our findings suggest that the UPR pathway is associated with the pathogenesis of HP.
Keyphrases
- endoplasmic reticulum stress
- endoplasmic reticulum
- induced apoptosis
- interstitial lung disease
- mouse model
- cell cycle arrest
- oxidative stress
- systemic sclerosis
- diffuse large b cell lymphoma
- cell death
- end stage renal disease
- endothelial cells
- binding protein
- rheumatoid arthritis
- drug induced
- ejection fraction
- chronic kidney disease
- prognostic factors
- signaling pathway
- newly diagnosed
- cell proliferation
- amino acid
- patient reported outcomes
- estrogen receptor
- pluripotent stem cells